Priority Date: 21.09.12 (US 201261704090P)

NATURALLY OCCURRING CPG OLIGONUCLEOTIDE COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF

  • Application ID: EP13840019
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
1127.69
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) J A Kemp is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 172 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.09.2012 - Priority Date (US 201261704090P)
  • 27.03.2014 - Publication A1 (WO2014047588)
  • 29.07.2015 - Publication A1 (EP2898073)